カテゴリ： GlobalInfoResearch, 世界, 医療/バイオ

世界のアリピプラゾール薬市場2022年：市場規模予測（～2028年）

■ 英語タイトル：Global Aripiprazole Drug Market 2022 by Manufacturers, Regions, Type and Application, Forecast to 2028

調査会社GlobalInfoResearch社が発行したリサーチレポート（データ管理コード：GIR22NO19160）■ 発行会社/調査会社：GlobalInfoResearch
■ 商品コード：GIR22NO19160
■ 発行日：2022年11月（※2025年版があります。お問い合わせください。）
■ 調査対象地域：グローバル
■ 産業分野：医薬品
■ ページ数：104
■ レポート言語：英語
■ レポート形式：PDF
■ 納品方式：Eメール（注文後2-3日）
■ 販売価格オプション（消費税別）
Single User（1名様閲覧用）USD3,480 ⇒換算￥528,960見積依頼/購入/質問フォーム
Multi User（20名様閲覧用）USD5,220 ⇒換算￥793,440見積依頼/購入/質問フォーム
Corporate User（同一法人内共有可）USD6,960 ⇒換算￥1,057,920見積依頼/購入/質問フォーム
※販売価格オプションの説明はこちらで、ご購入に関する詳細案内はご利用ガイドでご確認いただけます。
※お支払金額は「換算金額（日本円）＋消費税＋配送料（Eメール納品は無料）」です。
※Eメールによる納品の場合、通常ご注文当日～2日以内に納品致します。
※レポート納品後、納品日＋5日以内に請求書を発行・送付致します。（請求書発行日より2ヶ月以内の銀行振込条件、カード払いも可能）
※GlobalInfoResearch社の概要及び新刊レポートはこちらでご確認いただけます。
★グローバルリサーチ資料[世界のアリピプラゾール薬市場2022年：市場規模予測（～2028年）]についてメールでお問い合わせはこちら
*** レポート概要（サマリー）***

アリピプラゾール薬市場レポートは、世界の市場規模、地域および国レベルの市場規模、セグメント市場の成長性、市場シェア、競争環境、販売分析、国内および世界の市場プレーヤーの影響、バリューチェーンの最適化、最近の動向、機会分析、市場成長の戦略的な分析、製品発売、地域市場の拡大などに関する情報を提供します。
GlobalInfoResearchの最新の調査によると、世界のアリピプラゾール薬の市場規模は2021年のxxx米ドルから2028年にはxxx米ドルと推定され、xxx％の成長率で成長すると予想されます。

アリピプラゾール薬市場は種類と用途によって区分されます。2017年～2028年において、量と金額の観点から種類別および用途別セグメントの売上予測データを提供します。この分析は、適格なニッチ市場をターゲットにすることでビジネスを拡大するのに役立ちます。

種類別セグメントは次をカバーします。
・錠剤、口腔内崩壊錠、内服液、注射剤

用途別セグメントは次のように区分されます。
・成人患者、小児患者

世界のアリピプラゾール薬市場の主要な市場プレーヤーは以下のとおりです。
・Otsuka Pharmaceutical、Teva、APOTEX、Barr Laboratories、Sun Pharmaceutical、Alembic Pharmaceuticals、Orchid Pharma、Amneal、Aurobindo Pharma、Lannett

地域別セグメントは次の地域・国をカバーします。
・北米（米国、カナダ、メキシコ）
・ヨーロッパ（ドイツ、フランス、イギリス、ロシア、イタリア）
・アジア太平洋（日本、中国、韓国、インド、東南アジア、オーストラリア）
・南アメリカ（ブラジル、アルゼンチン、コロンビア）
・中東およびアフリカ（サウジアラビア、UAE、エジプト、南アフリカ）

本調査レポートの内容は計15章あります。
・第1章では、アリピプラゾール薬製品の調査範囲、市場の概要、市場の成長要因・阻害要因、および市場動向について説明します。
・第2章では、主要なアリピプラゾール薬メーカーの企業概要、2019年～2022年までのアリピプラゾール薬の価格、販売量、売上、市場シェアを掲載しています。
・第3章では、主要なアリピプラゾール薬メーカーの競争状況、販売量、売上、世界市場シェアが重点的に比較分析されています。
・第4章では、2017年～2028年までの地域別アリピプラゾール薬の販売量、売上、成長性を示しています。
・第5、6章では、2017年～2028年までのアリピプラゾール薬の種類別と用途別の市場規模、市場シェアと成長率を掲載しています。
・第7、8、9、10、11章では、2017年～2022年までの世界の主要国での販売量、売上、市場シェア、並びに2023年～2028年までの主要地域でのアリピプラゾール薬市場予測を収録しています。
・第12章では、主要な原材料、主要なサプライヤー、およびアリピプラゾール薬の産業チェーンを掲載しています。
・第13、14、15章では、アリピプラゾール薬の販売チャネル、販売業者、顧客、調査結果と結論、付録、データソースなどについて説明します。

***** 目次(一部) *****

・市場概要
- アリピプラゾール薬の概要
- 種類別分析（2017年vs2021年vs2028年）：錠剤、口腔内崩壊錠、内服液、注射剤
- 用途別分析（2017年vs2021年vs2028年）：成人患者、小児患者
- 世界のアリピプラゾール薬市場規模・予測
- 世界のアリピプラゾール薬生産能力分析
- 市場の成長要因・阻害要因・動向
・メーカー情報（企業概要、製品概要、販売量、価格、売上）
- Otsuka Pharmaceutical、Teva、APOTEX、Barr Laboratories、Sun Pharmaceutical、Alembic Pharmaceuticals、Orchid Pharma、Amneal、Aurobindo Pharma、Lannett
・メーカー別市場シェア・市場集中度
・地域別市場分析2017年-2028年
・種類別分析2017年-2028年：錠剤、口腔内崩壊錠、内服液、注射剤
・用途別分析2017年-2028年：成人患者、小児患者
・アリピプラゾール薬の北米市場
- 種類別市場規模2017年-2028年
- 用途別市場規模2017年-2028年
- 主要国別市場規模：アメリカ、カナダ、メキシコなど
・アリピプラゾール薬のヨーロッパ市場
- 種類別市場規模2017年-2028年
- 用途別市場規模2017年-2028年
- 主要国別市場規模：ドイツ、イギリス、フランス、ロシア、イタリアなど
・アリピプラゾール薬のアジア市場
- 種類別市場規模2017年-2028年
- 用途別市場規模2017年-2028年
- 主要国別市場規模：中国、日本、韓国、インド、東南アジア、オーストラリアなど
・アリピプラゾール薬の南米市場
- 種類別市場規模2017年-2028年
- 用途別市場規模2017年-2028年
- 主要国別市場規模：ブラジル、アルゼンチンなど
・アリピプラゾール薬の中東・アフリカ市場
- 種類別市場規模2017年-2028年
- 用途別市場規模2017年-2028年
- 主要国別市場規模：サウジアラビア、トルコ、エジプト、南アフリカなど
・原材料および産業チェーン
・販売チャネル、流通業者・代理店、顧客リスト
・調査の結果・結論

The Aripiprazole Drug market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, value chain optimization, trade regulations, recent developments, opportunities analysis, strategic market growth analysis, product launches, area marketplace expanding, and technological innovations.
According to our (Global Info Research) latest study, due to COVID-19 pandemic, the global Aripiprazole Drug market size is estimated to be worth US$ million in 2021 and is forecast to a readjusted size of USD million by 2028 with a CAGR of % during review period. Adult Patients accounting for % of the Aripiprazole Drug global market in 2021, is projected to value USD million by 2028, growing at a % CAGR in next six years. While Tablets segment is altered to a % CAGR between 2022 and 2028.
Global key manufacturers of Aripiprazole Drug include Otsuka Pharmaceutical, Teva, APOTEX, Barr Laboratories, and Sun Pharmaceutical, etc. In terms of revenue, the global top four players hold a share over % in 2021.
Market segmentation
Aripiprazole Drug market is split by Type and by Application. For the period 2017-2028, the growth among segments provide accurate calculations and forecasts for sales by Type and by Application in terms of volume and value. This analysis can help you expand your business by targeting qualified niche markets.
Market segment by Type, covers
Tablets
Orally Disintegrating Tablets
Oral Solution
Injection
Market segment by Application can be divided into
Adult Patients
Pediatric Patients
The key market players for global Aripiprazole Drug market are listed below:
Otsuka Pharmaceutical
Teva
APOTEX
Barr Laboratories
Sun Pharmaceutical
Alembic Pharmaceuticals
Orchid Pharma
Amneal
Aurobindo Pharma
Lannett
Market segment by region, regional analysis covers
North America (United States, Canada and Mexico)
Europe (Germany, France, United Kingdom, Russia, Italy, and Rest of Europe)
Asia-Pacific (China, Japan, Korea, India, Southeast Asia, and Australia)
South America (Brazil, Argentina, Colombia, and Rest of South America)
Middle East & Africa (Saudi Arabia, UAE, Egypt, South Africa, and Rest of Middle East & Africa)
The content of the study subjects, includes a total of 15 chapters:
Chapter 1, to describe Aripiprazole Drug product scope, market overview, market opportunities, market driving force and market risks.
Chapter 2, to profile the top manufacturers of Aripiprazole Drug, with price, sales, revenue and global market share of Aripiprazole Drug from 2019 to 2022.
Chapter 3, the Aripiprazole Drug competitive situation, sales, revenue and global market share of top manufacturers are analyzed emphatically by landscape contrast.
Chapter 4, the Aripiprazole Drug breakdown data are shown at the regional level, to show the sales, revenue and growth by regions, from 2017 to 2028.
Chapter 5 and 6, to segment the sales by Type and application, with sales market share and growth rate by type, application, from 2017 to 2028.
Chapter 7, 8, 9, 10 and 11, to break the sales data at the country level, with sales, revenue and market share for key countries in the world, from 2017 to 2022.and Aripiprazole Drug market forecast, by regions, type and application, with sales and revenue, from 2023 to 2028.
Chapter 12, the key raw materials and key suppliers, and industry chain of Aripiprazole Drug.
Chapter 13, 14, and 15, to describe Aripiprazole Drug sales channel, distributors, customers, research findings and conclusion, appendix and data source.

*** レポート目次（コンテンツ）***

1 Market Overview
1.1 Aripiprazole Drug Introduction
1.2 Market Analysis by Type
1.2.1 Overview: Global Aripiprazole Drug Revenue by Type: 2017 Versus 2021 Versus 2028
1.2.2 Tablets
1.2.3 Orally Disintegrating Tablets
1.2.4 Oral Solution
1.2.5 Injection
1.3 Market Analysis by Application
1.3.1 Overview: Global Aripiprazole Drug Revenue by Application: 2017 Versus 2021 Versus 2028
1.3.2 Adult Patients
1.3.3 Pediatric Patients
1.4 Global Aripiprazole Drug Market Size & Forecast
1.4.1 Global Aripiprazole Drug Sales in Value (2017 & 2021 & 2028)
1.4.2 Global Aripiprazole Drug Sales in Volume (2017-2028)
1.4.3 Global Aripiprazole Drug Price (2017-2028)
1.5 Global Aripiprazole Drug Production Capacity Analysis
1.5.1 Global Aripiprazole Drug Total Production Capacity (2017-2028)
1.5.2 Global Aripiprazole Drug Production Capacity by Geographic Region
1.6 Market Drivers, Restraints and Trends
1.6.1 Aripiprazole Drug Market Drivers
1.6.2 Aripiprazole Drug Market Restraints
1.6.3 Aripiprazole Drug Trends Analysis
2 Manufacturers Profiles
2.1 Otsuka Pharmaceutical
2.1.1 Otsuka Pharmaceutical Details
2.1.2 Otsuka Pharmaceutical Major Business
2.1.3 Otsuka Pharmaceutical Aripiprazole Drug Product and Services
2.1.4 Otsuka Pharmaceutical Aripiprazole Drug Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.2 Teva
2.2.1 Teva Details
2.2.2 Teva Major Business
2.2.3 Teva Aripiprazole Drug Product and Services
2.2.4 Teva Aripiprazole Drug Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.3 APOTEX
2.3.1 APOTEX Details
2.3.2 APOTEX Major Business
2.3.3 APOTEX Aripiprazole Drug Product and Services
2.3.4 APOTEX Aripiprazole Drug Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.4 Barr Laboratories
2.4.1 Barr Laboratories Details
2.4.2 Barr Laboratories Major Business
2.4.3 Barr Laboratories Aripiprazole Drug Product and Services
2.4.4 Barr Laboratories Aripiprazole Drug Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.5 Sun Pharmaceutical
2.5.1 Sun Pharmaceutical Details
2.5.2 Sun Pharmaceutical Major Business
2.5.3 Sun Pharmaceutical Aripiprazole Drug Product and Services
2.5.4 Sun Pharmaceutical Aripiprazole Drug Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.6 Alembic Pharmaceuticals
2.6.1 Alembic Pharmaceuticals Details
2.6.2 Alembic Pharmaceuticals Major Business
2.6.3 Alembic Pharmaceuticals Aripiprazole Drug Product and Services
2.6.4 Alembic Pharmaceuticals Aripiprazole Drug Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.7 Orchid Pharma
2.7.1 Orchid Pharma Details
2.7.2 Orchid Pharma Major Business
2.7.3 Orchid Pharma Aripiprazole Drug Product and Services
2.7.4 Orchid Pharma Aripiprazole Drug Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.8 Amneal
2.8.1 Amneal Details
2.8.2 Amneal Major Business
2.8.3 Amneal Aripiprazole Drug Product and Services
2.8.4 Amneal Aripiprazole Drug Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.9 Aurobindo Pharma
2.9.1 Aurobindo Pharma Details
2.9.2 Aurobindo Pharma Major Business
2.9.3 Aurobindo Pharma Aripiprazole Drug Product and Services
2.9.4 Aurobindo Pharma Aripiprazole Drug Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.10 Lannett
2.10.1 Lannett Details
2.10.2 Lannett Major Business
2.10.3 Lannett Aripiprazole Drug Product and Services
2.10.4 Lannett Aripiprazole Drug Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
3 Aripiprazole Drug Breakdown Data by Manufacturer
3.1 Global Aripiprazole Drug Sales in Volume by Manufacturer (2019, 2020, 2021, and 2022)
3.2 Global Aripiprazole Drug Revenue by Manufacturer (2019, 2020, 2021, and 2022)
3.3 Key Manufacturer Market Position in Aripiprazole Drug
3.4 Market Concentration Rate
3.4.1 Top 3 Aripiprazole Drug Manufacturer Market Share in 2021
3.4.2 Top 6 Aripiprazole Drug Manufacturer Market Share in 2021
3.5 Global Aripiprazole Drug Production Capacity by Company: 2021 VS 2022
3.6 Manufacturer by Geography: Head Office and Aripiprazole Drug Production Site
3.7 New Entrant and Capacity Expansion Plans
3.8 Mergers & Acquisitions
4 Market Analysis by Region
4.1 Global Aripiprazole Drug Market Size by Region
4.1.1 Global Aripiprazole Drug Sales in Volume by Region (2017-2028)
4.1.2 Global Aripiprazole Drug Revenue by Region (2017-2028)
4.2 North America Aripiprazole Drug Revenue (2017-2028)
4.3 Europe Aripiprazole Drug Revenue (2017-2028)
4.4 Asia-Pacific Aripiprazole Drug Revenue (2017-2028)
4.5 South America Aripiprazole Drug Revenue (2017-2028)
4.6 Middle East and Africa Aripiprazole Drug Revenue (2017-2028)
5 Market Segment by Type
5.1 Global Aripiprazole Drug Sales in Volume by Type (2017-2028)
5.2 Global Aripiprazole Drug Revenue by Type (2017-2028)
5.3 Global Aripiprazole Drug Price by Type (2017-2028)
6 Market Segment by Application
6.1 Global Aripiprazole Drug Sales in Volume by Application (2017-2028)
6.2 Global Aripiprazole Drug Revenue by Application (2017-2028)
6.3 Global Aripiprazole Drug Price by Application (2017-2028)
7 North America by Country, by Type, and by Application
7.1 North America Aripiprazole Drug Sales by Type (2017-2028)
7.2 North America Aripiprazole Drug Sales by Application (2017-2028)
7.3 North America Aripiprazole Drug Market Size by Country
7.3.1 North America Aripiprazole Drug Sales in Volume by Country (2017-2028)
7.3.2 North America Aripiprazole Drug Revenue by Country (2017-2028)
7.3.3 United States Market Size and Forecast (2017-2028)
7.3.4 Canada Market Size and Forecast (2017-2028)
7.3.5 Mexico Market Size and Forecast (2017-2028)
8 Europe by Country, by Type, and by Application
8.1 Europe Aripiprazole Drug Sales by Type (2017-2028)
8.2 Europe Aripiprazole Drug Sales by Application (2017-2028)
8.3 Europe Aripiprazole Drug Market Size by Country
8.3.1 Europe Aripiprazole Drug Sales in Volume by Country (2017-2028)
8.3.2 Europe Aripiprazole Drug Revenue by Country (2017-2028)
8.3.3 Germany Market Size and Forecast (2017-2028)
8.3.4 France Market Size and Forecast (2017-2028)
8.3.5 United Kingdom Market Size and Forecast (2017-2028)
8.3.6 Russia Market Size and Forecast (2017-2028)
8.3.7 Italy Market Size and Forecast (2017-2028)
9 Asia-Pacific by Region, by Type, and by Application
9.1 Asia-Pacific Aripiprazole Drug Sales by Type (2017-2028)
9.2 Asia-Pacific Aripiprazole Drug Sales by Application (2017-2028)
9.3 Asia-Pacific Aripiprazole Drug Market Size by Region
9.3.1 Asia-Pacific Aripiprazole Drug Sales in Volume by Region (2017-2028)
9.3.2 Asia-Pacific Aripiprazole Drug Revenue by Region (2017-2028)
9.3.3 China Market Size and Forecast (2017-2028)
9.3.4 Japan Market Size and Forecast (2017-2028)
9.3.5 Korea Market Size and Forecast (2017-2028)
9.3.6 India Market Size and Forecast (2017-2028)
9.3.7 Southeast Asia Market Size and Forecast (2017-2028)
9.3.8 Australia Market Size and Forecast (2017-2028)
10 South America by Region, by Type, and by Application
10.1 South America Aripiprazole Drug Sales by Type (2017-2028)
10.2 South America Aripiprazole Drug Sales by Application (2017-2028)
10.3 South America Aripiprazole Drug Market Size by Country
10.3.1 South America Aripiprazole Drug Sales in Volume by Country (2017-2028)
10.3.2 South America Aripiprazole Drug Revenue by Country (2017-2028)
10.3.3 Brazil Market Size and Forecast (2017-2028)
10.3.4 Argentina Market Size and Forecast (2017-2028)
11 Middle East & Africa by Country, by Type, and by Application
11.1 Middle East & Africa Aripiprazole Drug Sales by Type (2017-2028)
11.2 Middle East & Africa Aripiprazole Drug Sales by Application (2017-2028)
11.3 Middle East & Africa Aripiprazole Drug Market Size by Country
11.3.1 Middle East & Africa Aripiprazole Drug Sales in Volume by Country (2017-2028)
11.3.2 Middle East & Africa Aripiprazole Drug Revenue by Country (2017-2028)
11.3.3 Turkey Market Size and Forecast (2017-2028)
11.3.4 Egypt Market Size and Forecast (2017-2028)
11.3.5 Saudi Arabia Market Size and Forecast (2017-2028)
11.3.6 South Africa Market Size and Forecast (2017-2028)
12 Raw Material and Industry Chain
12.1 Raw Material of Aripiprazole Drug and Key Manufacturers
12.2 Manufacturing Costs Percentage of Aripiprazole Drug
12.3 Aripiprazole Drug Production Process
12.4 Aripiprazole Drug Industrial Chain
13 Sales Channel, Distributors, Traders and Dealers
13.1 Sales Channel
13.1.1 Direct Marketing
13.1.2 Indirect Marketing
13.2 Aripiprazole Drug Typical Distributors
13.3 Aripiprazole Drug Typical Customers
14 Research Findings and Conclusion
15 Appendix
15.1 Methodology
15.2 Research Process and Data Source
15.3 Disclaimer

List of Tables
Table 1. Global Aripiprazole Drug Revenue by Type, (USD Million), 2017 & 2021 & 2028
Table 2. Global Aripiprazole Drug Revenue by Application, (USD Million), 2017 & 2021 & 2028
Table 3. Otsuka Pharmaceutical Basic Information, Manufacturing Base and Competitors
Table 4. Otsuka Pharmaceutical Major Business
Table 5. Otsuka Pharmaceutical Aripiprazole Drug Product and Services
Table 6. Otsuka Pharmaceutical Aripiprazole Drug Sales (K Units), Price (USD/Unit), Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 7. Teva Basic Information, Manufacturing Base and Competitors
Table 8. Teva Major Business
Table 9. Teva Aripiprazole Drug Product and Services
Table 10. Teva Aripiprazole Drug Sales (K Units), Price (USD/Unit), Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 11. APOTEX Basic Information, Manufacturing Base and Competitors
Table 12. APOTEX Major Business
Table 13. APOTEX Aripiprazole Drug Product and Services
Table 14. APOTEX Aripiprazole Drug Sales (K Units), Price (USD/Unit), Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 15. Barr Laboratories Basic Information, Manufacturing Base and Competitors
Table 16. Barr Laboratories Major Business
Table 17. Barr Laboratories Aripiprazole Drug Product and Services
Table 18. Barr Laboratories Aripiprazole Drug Sales (K Units), Price (USD/Unit), Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 19. Sun Pharmaceutical Basic Information, Manufacturing Base and Competitors
Table 20. Sun Pharmaceutical Major Business
Table 21. Sun Pharmaceutical Aripiprazole Drug Product and Services
Table 22. Sun Pharmaceutical Aripiprazole Drug Sales (K Units), Price (USD/Unit), Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 23. Alembic Pharmaceuticals Basic Information, Manufacturing Base and Competitors
Table 24. Alembic Pharmaceuticals Major Business
Table 25. Alembic Pharmaceuticals Aripiprazole Drug Product and Services
Table 26. Alembic Pharmaceuticals Aripiprazole Drug Sales (K Units), Price (USD/Unit), Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 27. Orchid Pharma Basic Information, Manufacturing Base and Competitors
Table 28. Orchid Pharma Major Business
Table 29. Orchid Pharma Aripiprazole Drug Product and Services
Table 30. Orchid Pharma Aripiprazole Drug Sales (K Units), Price (USD/Unit), Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 31. Amneal Basic Information, Manufacturing Base and Competitors
Table 32. Amneal Major Business
Table 33. Amneal Aripiprazole Drug Product and Services
Table 34. Amneal Aripiprazole Drug Sales (K Units), Price (USD/Unit), Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 35. Aurobindo Pharma Basic Information, Manufacturing Base and Competitors
Table 36. Aurobindo Pharma Major Business
Table 37. Aurobindo Pharma Aripiprazole Drug Product and Services
Table 38. Aurobindo Pharma Aripiprazole Drug Sales (K Units), Price (USD/Unit), Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 39. Lannett Basic Information, Manufacturing Base and Competitors
Table 40. Lannett Major Business
Table 41. Lannett Aripiprazole Drug Product and Services
Table 42. Lannett Aripiprazole Drug Sales (K Units), Price (USD/Unit), Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 43. Global Aripiprazole Drug Sales by Manufacturer (2019, 2020, 2021, and 2022) & (K Units)
Table 44. Global Aripiprazole Drug Revenue by Manufacturer (2019, 2020, 2021, and 2022) & (USD Million)
Table 45. Market Position of Manufacturers in Aripiprazole Drug, (Tier 1, Tier 2, and Tier 3), Based on Revenue in 2021
Table 46. Global Aripiprazole Drug Production Capacity by Company, (K Units): 2020 VS 2021
Table 47. Head Office and Aripiprazole Drug Production Site of Key Manufacturer
Table 48. Aripiprazole Drug New Entrant and Capacity Expansion Plans
Table 49. Aripiprazole Drug Mergers & Acquisitions in the Past Five Years
Table 50. Global Aripiprazole Drug Sales by Region (2017-2022) & (K Units)
Table 51. Global Aripiprazole Drug Sales by Region (2023-2028) & (K Units)
Table 52. Global Aripiprazole Drug Revenue by Region (2017-2022) & (USD Million)
Table 53. Global Aripiprazole Drug Revenue by Region (2023-2028) & (USD Million)
Table 54. Global Aripiprazole Drug Sales by Type (2017-2022) & (K Units)
Table 55. Global Aripiprazole Drug Sales by Type (2023-2028) & (K Units)
Table 56. Global Aripiprazole Drug Revenue by Type (2017-2022) & (USD Million)
Table 57. Global Aripiprazole Drug Revenue by Type (2023-2028) & (USD Million)
Table 58. Global Aripiprazole Drug Price by Type (2017-2022) & (USD/Unit)
Table 59. Global Aripiprazole Drug Price by Type (2023-2028) & (USD/Unit)
Table 60. Global Aripiprazole Drug Sales by Application (2017-2022) & (K Units)
Table 61. Global Aripiprazole Drug Sales by Application (2023-2028) & (K Units)
Table 62. Global Aripiprazole Drug Revenue by Application (2017-2022) & (USD Million)
Table 63. Global Aripiprazole Drug Revenue by Application (2023-2028) & (USD Million)
Table 64. Global Aripiprazole Drug Price by Application (2017-2022) & (USD/Unit)
Table 65. Global Aripiprazole Drug Price by Application (2023-2028) & (USD/Unit)
Table 66. North America Aripiprazole Drug Sales by Country (2017-2022) & (K Units)
Table 67. North America Aripiprazole Drug Sales by Country (2023-2028) & (K Units)
Table 68. North America Aripiprazole Drug Revenue by Country (2017-2022) & (USD Million)
Table 69. North America Aripiprazole Drug Revenue by Country (2023-2028) & (USD Million)
Table 70. North America Aripiprazole Drug Sales by Type (2017-2022) & (K Units)
Table 71. North America Aripiprazole Drug Sales by Type (2023-2028) & (K Units)
Table 72. North America Aripiprazole Drug Sales by Application (2017-2022) & (K Units)
Table 73. North America Aripiprazole Drug Sales by Application (2023-2028) & (K Units)
Table 74. Europe Aripiprazole Drug Sales by Country (2017-2022) & (K Units)
Table 75. Europe Aripiprazole Drug Sales by Country (2023-2028) & (K Units)
Table 76. Europe Aripiprazole Drug Revenue by Country (2017-2022) & (USD Million)
Table 77. Europe Aripiprazole Drug Revenue by Country (2023-2028) & (USD Million)
Table 78. Europe Aripiprazole Drug Sales by Type (2017-2022) & (K Units)
Table 79. Europe Aripiprazole Drug Sales by Type (2023-2028) & (K Units)
Table 80. Europe Aripiprazole Drug Sales by Application (2017-2022) & (K Units)
Table 81. Europe Aripiprazole Drug Sales by Application (2023-2028) & (K Units)
Table 82. Asia-Pacific Aripiprazole Drug Sales by Region (2017-2022) & (K Units)
Table 83. Asia-Pacific Aripiprazole Drug Sales by Region (2023-2028) & (K Units)
Table 84. Asia-Pacific Aripiprazole Drug Revenue by Region (2017-2022) & (USD Million)
Table 85. Asia-Pacific Aripiprazole Drug Revenue by Region (2023-2028) & (USD Million)
Table 86. Asia-Pacific Aripiprazole Drug Sales by Type (2017-2022) & (K Units)
Table 87. Asia-Pacific Aripiprazole Drug Sales by Type (2023-2028) & (K Units)
Table 88. Asia-Pacific Aripiprazole Drug Sales by Application (2017-2022) & (K Units)
Table 89. Asia-Pacific Aripiprazole Drug Sales by Application (2023-2028) & (K Units)
Table 90. South America Aripiprazole Drug Sales by Country (2017-2022) & (K Units)
Table 91. South America Aripiprazole Drug Sales by Country (2023-2028) & (K Units)
Table 92. South America Aripiprazole Drug Revenue by Country (2017-2022) & (USD Million)
Table 93. South America Aripiprazole Drug Revenue by Country (2023-2028) & (USD Million)
Table 94. South America Aripiprazole Drug Sales by Type (2017-2022) & (K Units)
Table 95. South America Aripiprazole Drug Sales by Type (2023-2028) & (K Units)
Table 96. South America Aripiprazole Drug Sales by Application (2017-2022) & (K Units)
Table 97. South America Aripiprazole Drug Sales by Application (2023-2028) & (K Units)
Table 98. Middle East & Africa Aripiprazole Drug Sales by Region (2017-2022) & (K Units)
Table 99. Middle East & Africa Aripiprazole Drug Sales by Region (2023-2028) & (K Units)
Table 100. Middle East & Africa Aripiprazole Drug Revenue by Region (2017-2022) & (USD Million)
Table 101. Middle East & Africa Aripiprazole Drug Revenue by Region (2023-2028) & (USD Million)
Table 102. Middle East & Africa Aripiprazole Drug Sales by Type (2017-2022) & (K Units)
Table 103. Middle East & Africa Aripiprazole Drug Sales by Type (2023-2028) & (K Units)
Table 104. Middle East & Africa Aripiprazole Drug Sales by Application (2017-2022) & (K Units)
Table 105. Middle East & Africa Aripiprazole Drug Sales by Application (2023-2028) & (K Units)
Table 106. Aripiprazole Drug Raw Material
Table 107. Key Manufacturers of Aripiprazole Drug Raw Materials
Table 108. Direct Channel Pros & Cons
Table 109. Indirect Channel Pros & Cons
Table 110. Aripiprazole Drug Typical Distributors
Table 111. Aripiprazole Drug Typical Customers
List of Figures
Figure 1. Aripiprazole Drug Picture
Figure 2. Global Aripiprazole Drug Revenue Market Share by Type in 2021
Figure 3. Tablets
Figure 4. Orally Disintegrating Tablets
Figure 5. Oral Solution
Figure 6. Injection
Figure 7. Global Aripiprazole Drug Revenue Market Share by Application in 2021
Figure 8. Adult Patients
Figure 9. Pediatric Patients
Figure 10. Global Aripiprazole Drug Revenue, (USD Million) & (K Units): 2017 & 2021 & 2028
Figure 11. Global Aripiprazole Drug Revenue and Forecast (2017-2028) & (USD Million)
Figure 12. Global Aripiprazole Drug Sales (2017-2028) & (K Units)
Figure 13. Global Aripiprazole Drug Price (2017-2028) & (USD/Unit)
Figure 14. Global Aripiprazole Drug Production Capacity (2017-2028) & (K Units)
Figure 15. Global Aripiprazole Drug Production Capacity by Geographic Region: 2022 VS 2028
Figure 16. Aripiprazole Drug Market Drivers
Figure 17. Aripiprazole Drug Market Restraints
Figure 18. Aripiprazole Drug Market Trends
Figure 19. Global Aripiprazole Drug Sales Market Share by Manufacturer in 2021
Figure 20. Global Aripiprazole Drug Revenue Market Share by Manufacturer in 2021
Figure 21. Aripiprazole Drug Market Share by Company Type (Tier 1, Tier 2, and Tier 3) in 2021
Figure 22. Top 3 Aripiprazole Drug Manufacturer (Revenue) Market Share in 2021
Figure 23. Top 6 Aripiprazole Drug Manufacturer (Revenue) Market Share in 2021
Figure 24. Global Aripiprazole Drug Sales Market Share by Region (2017-2028)
Figure 25. Global Aripiprazole Drug Revenue Market Share by Region (2017-2028)
Figure 26. North America Aripiprazole Drug Revenue (2017-2028) & (USD Million)
Figure 27. Europe Aripiprazole Drug Revenue (2017-2028) & (USD Million)
Figure 28. Asia-Pacific Aripiprazole Drug Revenue (2017-2028) & (USD Million)
Figure 29. South America Aripiprazole Drug Revenue (2017-2028) & (USD Million)
Figure 30. Middle East & Africa Aripiprazole Drug Revenue (2017-2028) & (USD Million)
Figure 31. Global Aripiprazole Drug Sales Market Share by Type (2017-2028)
Figure 32. Global Aripiprazole Drug Revenue Market Share by Type (2017-2028)
Figure 33. Global Aripiprazole Drug Price by Type (2017-2028) & (USD/Unit)
Figure 34. Global Aripiprazole Drug Sales Market Share by Application (2017-2028)
Figure 35. Global Aripiprazole Drug Revenue Market Share by Application (2017-2028)
Figure 36. Global Aripiprazole Drug Price by Application (2017-2028) & (USD/Unit)
Figure 37. North America Aripiprazole Drug Sales Market Share by Type (2017-2028)
Figure 38. North America Aripiprazole Drug Sales Market Share by Application (2017-2028)
Figure 39. North America Aripiprazole Drug Sales Market Share by Country (2017-2028)
Figure 40. North America Aripiprazole Drug Revenue Market Share by Country (2017-2028)
Figure 41. United States Aripiprazole Drug Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 42. Canada Aripiprazole Drug Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 43. Mexico Aripiprazole Drug Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 44. Europe Aripiprazole Drug Sales Market Share by Type (2017-2028)
Figure 45. Europe Aripiprazole Drug Sales Market Share by Application (2017-2028)
Figure 46. Europe Aripiprazole Drug Sales Market Share by Country (2017-2028)
Figure 47. Europe Aripiprazole Drug Revenue Market Share by Country (2017-2028)
Figure 48. Germany Aripiprazole Drug Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 49. France Aripiprazole Drug Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 50. United Kingdom Aripiprazole Drug Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 51. Russia Aripiprazole Drug Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 52. Italy Aripiprazole Drug Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 53. Asia-Pacific Aripiprazole Drug Sales Market Share by Region (2017-2028)
Figure 54. Asia-Pacific Aripiprazole Drug Sales Market Share by Application (2017-2028)
Figure 55. Asia-Pacific Aripiprazole Drug Sales Market Share by Region (2017-2028)
Figure 56. Asia-Pacific Aripiprazole Drug Revenue Market Share by Region (2017-2028)
Figure 57. China Aripiprazole Drug Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 58. Japan Aripiprazole Drug Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 59. Korea Aripiprazole Drug Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 60. India Aripiprazole Drug Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 61. Southeast Asia Aripiprazole Drug Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 62. Australia Aripiprazole Drug Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 63. South America Aripiprazole Drug Sales Market Share by Type (2017-2028)
Figure 64. South America Aripiprazole Drug Sales Market Share by Application (2017-2028)
Figure 65. South America Aripiprazole Drug Sales Market Share by Country (2017-2028)
Figure 66. South America Aripiprazole Drug Revenue Market Share by Country (2017-2028)
Figure 67. Brazil Aripiprazole Drug Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 68. Argentina Aripiprazole Drug Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 69. Middle East & Africa Aripiprazole Drug Sales Market Share by Type (2017-2028)
Figure 70. Middle East & Africa Aripiprazole Drug Sales Market Share by Application (2017-2028)
Figure 71. Middle East & Africa Aripiprazole Drug Sales Market Share by Region (2017-2028)
Figure 72. Middle East & Africa Aripiprazole Drug Revenue Market Share by Region (2017-2028)
Figure 73. Turkey Aripiprazole Drug Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 74. Egypt Aripiprazole Drug Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 75. Saudi Arabia Aripiprazole Drug Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 76. South Africa Aripiprazole Drug Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 77. Manufacturing Cost Structure Analysis of Aripiprazole Drug in 2021
Figure 78. Manufacturing Process Analysis of Aripiprazole Drug
Figure 79. Aripiprazole Drug Industrial Chain
Figure 80. Sales Channel: Direct Channel vs Indirect Channel
Figure 81. Methodology
Figure 82. Research Process and Data Source


*** 免責事項 ***
https://www.globalresearch.co.jp/disclaimer/
※関連調査資料
  • 世界のゴセレリン薬物市場2022年：市場規模予測（～2028年）
  • 世界の神経線維腫症治療薬市場2022年：市場規模予測（～2028年）
  • 世界のCDK4及び6阻害医薬品市場2022年：市場規模予測（～2028年）
  • 世界のアフリベルセプト薬市場2022年：市場規模予測（～2028年）
  • 世界の軟骨形成術治療薬市場2022年：市場規模予測（～2028年）
    • ※注目の調査資料
     ※当サイト上のレポートデータは弊社H&Iグローバルリサーチ運営のMarketReport.jpサイトと連動しています。
    ※当市場調査資料(GIR22NO19160 )"世界のアリピプラゾール薬市場2022年：市場規模予測（～2028年）" (英文：Global Aripiprazole Drug Market 2022 by Manufacturers, Regions, Type and Application, Forecast to 2028)はGlobalInfoResearch社が調査・発行しており、H&Iグローバルリサーチが販売します。

    ◆H&Iグローバルリサーチのお客様（例）◆


    ※当サイトに掲載していない調査資料も弊社を通してご購入可能ですので、お気軽にご連絡ください。ウェブサイトでは紹介しきれない資料も数多くございます。
    ※無料翻訳ツールをご利用いただけます。翻訳可能なPDF納品ファイルが対象です。ご利用を希望されるお客様はご注文の時にその旨をお申し出ください。